MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41698-026-01543-6

Медицинская библиотека · NPJ precision oncology · 2026

Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligence.

Cole Sebastian, Campitelli Paul, Grieb Brian, Astsaturov Igor, Von Hoff Daniel, Singh Harshabad, Pishvaian Michael J, Bekaii-Saab Tanios S, Hosein Peter J, Philip Philip A, Helmstetter Anthony, Maney Todd, Ribeiro Jennifer R, Hamrick James, Magee Daniel, Spetzler David

СтатьяПеревод в очереди

Аннотация

Improved clinical outcomes are reported for patients with advanced pancreatic adenocarcinoma (PDAC) treated with first-line FOLFIRINOX/NALIRIFOX, but elderly patients with comorbidities are more often treated with gemcitabine/nab-paclitaxel (gem/nab-p). There is currently no comprehensive method to optimize first-line treatment selection between these regimens. We developed a propensity score matched, transcriptomic-based AI model using 2202 molecularly-profiled PDAC specimens to provide clinically relevant treatment recommendations and prognostic information. In a testing dataset of patients predicted to have superior outcomes on first-line FOLFIRINOX, time-to-next-treatment (TTNT) and overall survival (OS) were significantly longer for patients treated with FOLFIRINOX first (HRs = 0.55 and 0.48, respectively, p < 0.001). Patients recommended for gem/nab-p treatment had similar outcomes on either treatment, but a subset had improved outcomes on gem/nab-p. Approximately half of patients had received the opposite therapy from the model recommendation. Applied clinically, this model could improve treatment decision-making in advanced PDAC in the first-line setting.

Для цитирования: Cole Sebastian, Campitelli Paul, Grieb Brian, Astsaturov Igor, Von Hoff Daniel, Singh Harshabad, Pishvaian Michael J, Bekaii-Saab Tanios S, Hosein Peter J, Philip Philip A, Helmstetter Anthony, Maney Todd, Ribeiro Jennifer R, Hamrick James, Magee Daniel, Spetzler David. Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligence.. NPJ precision oncology. 2026. DOI: 10.1038/s41698-026-01543-6.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.